Cas:81476-73-5 cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride manufacturer & supplier

Chemical Name:cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride

CAS.NO:81476-73-5

Synonyms:1,3-Cyclopentadiene,1,2,3,4,5-pentamethyl-,zirconium complex

Molecular Formula:C₁₅H₂₀Cl₂Zr

Molecular Weight:362.44900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:359.99900

LogP:5.37250

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3-Cyclopentadiene,1,2,3,4,5-pentamethyl-,zirconium complex chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Cyclopentadiene,1,2,3,4,5-pentamethyl-,zirconium complex physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Cyclopentadiene,1,2,3,4,5-pentamethyl-,zirconium complex Use and application,1,3-Cyclopentadiene,1,2,3,4,5-pentamethyl-,zirconium complex technical grade,usp/ep/jp grade.

Related News: Both were in Siberia, and both are Chinese nationals who had recently traveled to China. cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride manufacturer Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride supplier Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. cyclopenta-1,3-diene,1,2,3,5,5-pentamethylcyclopenta-1,3-diene,zirconium(4+),dichloride factory Both were in Siberia, and both are Chinese nationals who had recently traveled to China.